COVID-19 Impact on Rheumatic Patients

COVID Clinical Trial

Official title:

Impact of COVID-19 Pandemic on Attitude, Behaviour and Mental Health of Patients With Rheumatic Diseases

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04407299
• Other study ID #: COVID-19Rheum
• Status: Completed
• Start date: April 20, 2020
• Est. completion date: May 20, 2020

Study information

• Verified date: July 2020
• Source: Cairo University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

A study to assess the impact of coronavirus disease 2019 (COVID-19) pandemic on the attitude, behaviour and mental health of rheumatic patients and to compare them with healthy individuals.

Description:

To assess the impact of coronavirus disease 2019 (COVID19) pandemic on the attitude, behaviour and mental health of rheumatic patients and to compare them with healthy individual. This is cross-sectional survey, 360 participants were included and divided into cases group composed of 180 patients with rheumatic diseases and control group composed of 180 healthy people. Data were collected via a self-administered structured questionnaire (Google form) which was sent to participants via social networks and emails to different rheumatic patients and healthy individuals. Mental health was measured by the five-item Brief Symptom Rating Scale (BSRS-5).

Conclusion: Mental health should be addressed in the same manner we deal with the infectious disease itself, being of no less importance. It is essential for mental health professionals provide psychological support to vulnerable populations, including the infected and chronically ill patients and their families, individuals, communities and health care workers.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 360
• Est. completion date: May 20, 2020
• Est. primary completion date: May 10, 2020
• Gender: All
• Age group: 16 Years and older

Eligibility

Inclusion Criteria:

• adult patient with diagnosed rheumatic disease

Exclusion Criteria:

-

Related Conditions & MeSH terms

• COVID
• Rheumatic Diseases

Intervention

Behavioral:
• self-administered structured questionnaire
It was designed as a self-administered questionnaire with closed questions (yes/no questions, rating scale and multiple choice questions) and some open ended questions.

Locations

Country	Name	City	State
Egypt	Kasr Alainy Hospital	Cairo	Non-US/Non-Canadian

Sponsors (2)

Lead Sponsor	Collaborator
Cairo University	Zagazig University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Score of five-item Brief Symptom Rating Scale (BSRS-5)	7. Six questions for mental health assessment for patients and controls: Mental health was measured by the five-item Brief Symptom Rating Scale (BSRS-5) which was derived from the 50-item BSRS	3 weeks